NSE - Delayed Quote • INR
Biocon Limited (BIOCON.NS)
At close: April 26 at 3:29 PM GMT+5:30
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 14 | 16 |
| Avg. Estimate | 1.3 | 1.19 | 6.26 | 8.05 |
| Low Estimate | 0.6 | 1.19 | 1.51 | 4.4 |
| High Estimate | 2.01 | 1.19 | 9.08 | 10.93 |
| Year Ago EPS | 2.59 | 0.85 | 3.84 | 6.26 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 1 | 17 | 17 |
| Avg. Estimate | 39.08B | 37.71B | 145.23B | 165.86B |
| Low Estimate | 37.3B | 37.71B | 138.21B | 153.97B |
| High Estimate | 41.06B | 37.71B | 153.42B | 181.4B |
| Year Ago Sales | 5.07B | 35.99B | 19.93B | 145.23B |
| Sales Growth (year/est) | 671.30% | 4.80% | 628.70% | 14.20% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.92 | 1.68 | 1.46 | 1.62 |
| EPS Actual | 2.59 | 0.85 | 1.25 | 5.33 |
| Difference | 0.67 | -0.83 | -0.21 | 3.71 |
| Surprise % | 34.90% | -49.40% | -14.40% | 229.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.3 | 1.19 | 6.26 | 8.05 |
| 7 Days Ago | 1.95 | 2.85 | 6.15 | 8.29 |
| 30 Days Ago | 3.3 | 2.85 | 6.1 | 8.38 |
| 60 Days Ago | 3.3 | 2.85 | 6.1 | 8.38 |
| 90 Days Ago | 3.06 | 3.07 | 6.2 | 10.67 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | BIOCON.NS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -49.80% | -- | -- | 5.40% |
| Next Qtr. | 40.00% | -- | -- | 10.90% |
| Current Year | 63.00% | -- | -- | 4.50% |
| Next Year | 28.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 62.70% | -- | -- | 10.94% |
| Past 5 Years (per annum) | 2.83% | -- | -- | -- |
Research Analysis
Related Tickers
SYNGENE.NS Syngene International Limited
698.60
-0.07%
LYKALABS.NS Lyka Labs Limited
123.15
-2.26%
BLUEJET.NS Blue Jet Healthcare Limited
384.60
-1.83%
SUPRIYA.NS Supriya Lifescience Limited
409.50
-1.04%
DCAL.NS Dishman Carbogen Amcis Limited
229.65
-1.61%
CONCORDBIO.NS Concord Biotech Limited
1,660.05
+1.45%
TRML Tourmaline Bio, Inc.
15.68
-2.00%
NUVL Nuvalent, Inc.
66.86
+1.20%
FDMT 4D Molecular Therapeutics, Inc.
23.25
-1.19%
PANACEABIO.NS Panacea Biotec Limited
143.65
-1.95%